CHARLES RIVER LABORATORIES INTERNATIONAL
Charles River Laboratories International, Inc. provides solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Segments The company has two segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. RESEARCH MODELS AND SERVICES (RMS) The company supplies research models to the drug development industry. With approximately 150 different... strains the company engages in the production and sale of research models, principally genetically and virally defined purpose-bred rats and mice. It also provides various related services that are designed to assist customers in supporting the use of research models in drug development. With multiple facilities located on three continents (North America, Europe and Asia (Japan)), the company maintains production centers, including a total of approximately 180 barrier rooms or isolator facilities located near its customers. RMS segment comprises Research Models, Research Model Services, and other related products and services
CHARLES RIVER LABORATORIES INTERNATIONAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1947-01-01
Address:
Wilmington, Massachusetts, United States
Country:
United States
Website Url:
http://www.criver.com
Total Employee:
5001+
Status:
Active
Contact:
(781)222-6000
Total Funding:
1.53 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box Euro
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-04-06 | Explora BioLabs | Explora BioLabs acquired by Charles River Laboratories International | 295 M USD |
2021-05-17 | Vigene Biosciences | Vigene Biosciences acquired by Charles River Laboratories International | 292.5 M USD |
2021-03-31 | Retrogenix | Retrogenix acquired by Charles River Laboratories International | N/A |
2021-02-17 | Cognate BioServices | Cognate BioServices acquired by Charles River Laboratories International | 875 M USD |
2020-12-31 | Distributed Bio | Distributed Bio acquired by Charles River Laboratories International | 83 M USD |
2020-08-06 | Cellero | Cellero acquired by Charles River Laboratories International | 38 M USD |
2019-12-16 | HemaCare | HemaCare acquired by Charles River Laboratories International | N/A |
2019-02-13 | CiToxLAB | CiToxLAB acquired by Charles River Laboratories International | 448 M EUR |
2018-02-13 | MPI Research | MPI Research acquired by Charles River Laboratories International | 800 M USD |
2018-01-11 | KWS BioTest | KWS BioTest acquired by Charles River Laboratories International | N/A |
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Charles River Laboratories International
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-06-02 | Vernal Biosciences | Charles River Laboratories International investment in Venture Round - Vernal Biosciences | 21 M USD |
2022-05-19 | Deciphex | Charles River Laboratories International investment in Series B - Deciphex | 11.5 M USD |
2021-11-09 | PathoQuest | Charles River Laboratories International investment in Series B - PathoQuest | 15 M EUR |
2021-11-05 | bit.bio | Charles River Laboratories International investment in Series B - bit.bio | 103 M USD |
2019-09-06 | PathoQuest | Charles River Laboratories International investment in Venture Round - PathoQuest | 8 M EUR |
1997-01-01 | Aspect Medical Systems | Charles River Laboratories International investment in Venture Round - Aspect Medical Systems | 17.5 M USD |
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.criver.com Semrush global rank: 252.54 K Semrush visits lastest month: 273.61 K
- Host name: ec2-52-54-40-78.compute-1.amazonaws.com
- IP address: 52.54.40.78
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Charles River Laboratories International"
Charles River Laboratories | Boldly challenge scientific possibility
Charles River provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.See details»
Our Story | Charles River
Our Purpose. We are guided by our strong purpose โ to create healthier lives - which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, and to our people and planet. Every day we โฆSee details»
Charles River Laboratories - Wikipedia
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry (for eโฆSee details»
Our Story | Charles River - criver.quebec
Cognate BioServices, a premier cell and gene therapy contract development and manufacturing organization (CDMO), is acquired, expanding Charles Riverโs scientific capabilities into the emerging, high-growth cell and gene therapy โฆSee details»
Committee Composition - Charles River Laboratories International, โฆ
The Committee also makes recommendations to the Board on all matters relating to the Board, including development and implementation of policies on composition, participation and size of โฆSee details»
Charles River Laboratories Announces Organizational Changes to โฆ
WILMINGTON, Mass.--(BUSINESS WIRE)--Dec. 9, 2013-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced organizational changes which are designed โฆSee details»
Charles River Laboratories - LinkedIn
Charles River Laboratories | 197,123 followers on LinkedIn. Together, We Create Healthier Lives | At Charles River, we are guided by our strong purposeโto create healthier livesโwhich โฆSee details»
Investor Relations - Charles River Laboratories International, Inc.
WILMINGTON, Mass.--(BUSINESS WIRE)--Apr. 7, 2022-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the publication of its 2021 Corporate โฆSee details»
Contract Manufacturing Organization - Charles River โฆ
Contract Manufacturing Organization Contract manufacturing organizations' work may involve performing the work in-house or using a trusted CRO to outsource testing to. Other options to consider are qualifying a vendor to handle overflow โฆSee details»
Charles River Careers - Home
Find your moment to make a significant impact on global health with a career at Charles RiverSee details»
Investor Relations - Charles River Laboratories International, Inc.
"This transaction revolutionizes the contract research landscape by creating the only global contract research organization, or CRO, to offer fully integrated research and drug โฆSee details»
SUMMARY - 2024 Cell and Gene Therapy Summit - Charles River โฆ
Mar 19, 2024 SUMMARY - 2024 Cell and Gene Therapy Summit - Charles River LaboratoriesSee details»
Charles River - Overview, News & Similar companies - ZoomInfo
Aug 25, 2024 Charles River contact info: Phone number: (781) 222-6000 Website: www.criver.com What does Charles River do? For more than 75 years, Charles River has โฆSee details»
Charles River Products and Services
Hover or click on the segments of this chart to explore our products and services.See details»
Charles River and Genetic Cures for Kids Announce Gene Therapy ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 28, 2023-- Charles River Laboratories International, Inc. (NYSE: CRL) and Genetic Cures for Kids Inc (GC4K), an Australian non โฆSee details»
Supplier Information | Charles River - Charles River Laboratories
Our procurement organization, internal stakeholders, and others involved in the supplier selection process integrate small business into their business strategies and operations. We make good โฆSee details»
Sample Management Technician 1, Shrewsbury, MA - Charles โฆ
Find your moment to make a positive impact on global health with a career at Charles River.See details»
Vigene Biosciences Is Now Part of Charles River
Cell and Gene Therapy CDMO Facilities. Accelerate the development of your product and ensure it meets the highest regulatory standards while maintaining efficient production timelines โฆSee details»
Investor Relations - Charles River Laboratories International, Inc.
Apollo reduces barriers by providing valuable insights to enhance decision making abilities. WILMINGTON, Mass.--(BUSINESS WIRE)--Mar. 13, 2023-- Charles River Laboratories โฆSee details»
A New Criver.com Experience | Charles River
Mar 28, 2024 A New Criver.com Experience Website upgrades are ongoing to help improve your experience Throughout 2024, users can expect to see enhancements across site content, โฆSee details»